• Skip to primary navigation
  • Skip to main content
Neural Stem Cell Institute, Rensselaer NY

Neural Stem Cell Institute, Rensselaer NY

Stem cell research and applications in the treatment of diseases like Retinitis Pigmentosis, Alzheimer's, Parkinson's, Spinal Cord Injury, Retinal Degeneration. Home of SallyTemple's lab.

  • Home
  • Support NSCI
  • Research
    • Alzheimer’s Program
    • Retinal Disease: Age-Related Macular Degeneration
    • Parkinson’s Disease Program
    • Spinal Cord Injury Program
    • Computing @ NSCI
  • NeuraCell
  • Tau Consortium
  • News
  • About Us
    • Our Team
  • Contact Us
    • Careers
    • Volunteer Internship
    • Collaboration Inquiries
    • Media Inquiries
  • Show Search
Hide Search

Stem cell research to cure nervous system disease.

The Neural Stem Cell Institute (NSCI) is dedicated to developing regenerative stem cell therapies for diseases of the central nervous system (CNS): the brain, spinal cord and retina.

The Neural Stem Cell Institute

Intracellular Antibody Therapies

Our scientists are developing new antibody therapies to remove aggregated proteins due to tauopathies like Alzheimer’s Disease, FTD, PSP and CTE, Parkinson’s Disease and Huntington’s Disease.

Promoting Nervous System Self-repair

Our scientists are striving to activate stem cells that are present but normally dormant in the adult nervous system to mediate repair and regeneration.

NeuraCell Core Facility

NeuraCell is a not-for-profit core facility that provides unique stem cells, tools and services to support scientists, laboratories and companies.

Disease in a Dish Models

We use patient-derived stem cells to model degenerative diseases, including tauopathies like Alzheimer’s Disease, Parkinson’s Disease and Age-related Macular Degeneration.

Retina Repair

NSCI scientists discovered a new stem cell, the Retinal Pigment Epithelial Stem Cell, in the adult human retina that enables cell replacement therapies, disease modeling and drug discovery for blinding disorders.

Latest Blog Posts

Research using Stem Cells from Patients shows why Brain Tissue may Degenerate in Dementia.

Sally Temple
July 26, 2021

RENSSELAER NY – Neural Stem Cell Institute Scientists Advance Dementia Research Using 3D Brain Organoid Technology Patients with dementia suffer from tau protein aggregation and brain degeneration especially in the cerebral cortex, the major brain region responsible for decision-making, memory,…

Continue Reading Research using Stem Cells from Patients shows why Brain Tissue may Degenerate in Dementia.

NSCI IND Allowance for AMD Clinical Trial

Sally Temple
April 2, 2021

NSCI is pleased to announce our successful IND application to the FDA that will enable clinical testing of a novel stem cell therapy for patients with age-related macular degeneration (AMD). In AMD, the retinal pigment epithelial cells (RPE) at the…

Continue Reading NSCI IND Allowance for AMD Clinical Trial

NSCI Scientists Inspiring Girls in Science!

Khadijah Onanuga
September 7, 2018

Women scientists from the NSCI – Dr. Liz Fisher, Dr. Xiuli Zhao, and Christy Allen recently took part in the Flying Cloud Institute’s, Young Women In Science, STEM Summer Practicum Program. This program is aimed at inspiring young women to…

Continue Reading NSCI Scientists Inspiring Girls in Science!

Social

About

The Neural Stem Cell Institute (NSCI) develops regenerative therapies for the central nervous system (CNS): the brain, spinal cord and retina, regardless of the cause. Led by MacArthur “Genius” Award winner Dr. Sally Temple who helped discover and define nervous system stem cells, NSCI is the first independent, non-profit stem cell research institute in the USA.

Contact

Neural Stem Cell Institute
One Discovery Drive
Rensselaer, NY 12144

Phone: (518) 694-8188
Fax: (518) 694-8187
Email: info@neuralsci.org

Neural Stem Cell Institute, Rensselaer NY

Copyright © 2022 - This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • Home
  • Support NSCI
  • Research
  • NeuraCell
  • Tau Consortium
  • News
  • About Us
  • Contact Us